Michael Method, MD, MPH, MBA, is the Senior Vice President of Clinical Development at Bicycle Therapeutics, a position they currently hold. Previously, Method served as Executive Medical Director at ImmunoGen, Inc. from 2021 to 2024, and was the Director of Oncology Research at Community Health Network from 2016 to 2018. They also held roles such as Senior Vice President at Karyopharm Therapeutics and Senior Medical Advisor at Eli Lilly and Company. Method’s extensive education includes a Doctor of Medicine from Northwestern University and an Executive MBA from the University of Notre Dame.
This person is not in any teams
This person is not in any offices